CORRECTING and REPLACING Bruker Completes Divestiture of its Gas Chromatography Product Lines

CORRECTION...by Bruker Corporation

FREMONT, Calif.--()--Fourth paragraph, fourth sentence of release should read: Bruker will continue to service and support its GC-TQ and LC-TQ products indefinitely. (instead of Bruker will continue to service and support its GC-TQ and LC-TQ products unless Techcomp exercises its option to acquire the services business in the next twelve months.).

The corrected release reads: 

BRUKER COMPLETES DIVESTITURE OF ITS GAS CHROMATOGRAPHY PRODUCT LINES

Bruker Corporation (NASDAQ: BRKR) today announced that it completed the divestiture of its Gas Chromatography (GC) and GC single-quadrupole (GC-SQ) mass spectrometry products to Techcomp Europe Ltd., a subsidiary of Techcomp (Holdings) Ltd, on October 31st, 2014. Techcomp intends to continue to manufacture the former Bruker GC and GC-SQ SCION™ products in the Fremont, CA, factory previously occupied by Bruker’s Chemical and Applied Markets (CAM) division.

Select Bruker CAM GC and GC-SQ sales, marketing, applications and operations employees are expected to be offered positions with Techcomp. Bruker will continue to provide service and support for all GC and GC-SQ products worldwide. As part of the transaction, Techcomp has a deferred option to acquire the service business for GC and GC-SQ products in the next twelve months.

The GC product line divestiture is an important part of Bruker’s restructuring of its CAM division, which was announced in July 2014. In September 2014, Bruker’s CAM division divested its Inductively-Coupled Plasma Mass Spectrometry (ICP-MS) product line and service business to Analytik Jena AG.

Additionally, Bruker is also in the process of relocating the manufacturing of its GC triple-quadrupole and LC triple-quadrupole (GC-TQ and LC-TQ) mass spectrometers from Fremont, CA to Bremen, Germany. This relocation is expected to be finalized in the first half of 2015. Bruker’s GC-TQ and LC-TQ product research and development will be transferred to the Company’s major mass spectrometry sites in Bremen and Billerica, MA. Bruker will continue to service and support its GC-TQ and LC-TQ products indefinitely.

About TECHCOMP

TECHCOMP (HOLDINGS) Ltd. designs, develops, manufactures and distributes analytical instruments, life science equipment and laboratory instruments for a broad range of chemical analysis and life science applications. These instruments include gas and ion chromatography systems, UV-Vis spectrophotometers and centrifuges. The company is headquartered in Hong Kong, with manufacturing facilities in Shanghai, currently having 19 liaison offices throughout the PRC, a subsidiary office in Singapore, a representative office in Mumbai, India and a sales administration office in Macau. The Techcomp (Holdings) Ltd. ordinary shares are traded on the Stock Exchange of Hong Kong Limited (SEHK) as stock code 1298.

TECHCOMP Europe Ltd, based in the UK, comprises of a group of European companies involved in the manufacture and distribution of analytical systems, life science equipment and laboratory instruments with operations dating back to 1920. The group consists of Edinburgh Instruments - a leading photonics technology manufacturer, Froilabo - (with factories in France and Romania) specializing in Ultra Low Temperature technologies, Precisa - (manufacturing in Switzerland) offering a complete range of high precision metrology and weighing solutions and Dynamica - (based in the UK) that supplies a wide range of analytical and laboratory instruments. The group products are distributed across Europe with direct support from local factories and commercial teams, throughout Asia out of distribution operations in Hong Kong and across Latin America from a dedicated office in Mexico City. Techcomp Europe is owned by Techcomp (Holdings) Ltd.

About Bruker Corporation

Bruker Corporation is a leading provider of high-performance, scientific instruments and solutions for molecular, cellular and materials research, as well as diagnostics, industrial, clinical research and applied analysis. For more information, please visit www.bruker.com.

Contacts

Bruker Corporation
Joshua Young, 978-667–9580, ext. 1479
Vice President, Investor Relations
joshua.young@bruker.com

Contacts

Bruker Corporation
Joshua Young, 978-667–9580, ext. 1479
Vice President, Investor Relations
joshua.young@bruker.com